Compare $EIKN vs $USBC | Chartloom

Compare

$EIKN vs $USBC

Eikon Therapeutics Inc · USBC Inc

EIKN

Eikon Therapeutics Inc

USBC

USBC Inc

Compare $EIKN vs $USBC

Comparing Eikon Therapeutics Inc and USBC Inc

EIKNEikon Therapeutics Inc

USBCUSBC Inc

EIKNEikon Therapeutics Inc

Market cap

$404M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-50.2%

52W performance

-50.2%

FCF yield

-96.6%

USBCUSBC Inc

Market cap

$198M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-22.2%

52W performance

-51.9%

FCF yield

-11.6%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

EIKN

USBC

Detailed metrics comparison

EIKN

Eikon Therapeutics Inc

USBC

USBC Inc

Market Cap

EIKN$404M

USBC$198M

Enterprise Value

EIKN$262M

USBC$210M

Price

EIKN$7.47

USBC$0.51

P/E Ratio

EIKNN/A

USBCN/A

P/S Ratio

EIKN0.00x

USBC0.00x

EV/Sales

EIKN0.00x

USBC0.00x

EV/EBITDA

EIKN0.00x

USBC0.00x

P/B Ratio

EIKN0.85x

USBC4.46x

P/FCF Ratio

EIKNN/A

USBCN/A

EV/FCF

EIKN-0.67x

USBC-9.14x

PEG Ratio

EIKN0.00x

USBCN/A

Forward P/E (NTM)

EIKNN/A

USBCN/A

Forward P/S (NTM)

EIKNN/A

USBCN/A

Revenue (TTM)

EIKN$0

USBC$0

Revenue Growth (YoY)

EIKNN/A

USBCN/A

Forward Rev Growth

EIKN436.8%

USBC0.0%

Gross Margin (TTM)

EIKN0.0%

USBC0.0%

Operating Margin (TTM)

EIKN0.0%

USBC0.0%

EBITDA Margin (TTM)

EIKN0.0%

USBC0.0%

Net Margin (TTM)

EIKN0.0%

USBC0.0%

FCF Margin (TTM)

EIKNN/A

USBCN/A

Net Income (TTM)

EIKN$-505M

USBC$-86M

FCF (TTM)

EIKN$-391M

USBC$-23M

EPS (TTM)

EIKN-$9.33

USBC-$0.22

ROE (TTM)

EIKN-11966.0%

USBC-12093.0%

ROA (TTM)

EIKN-6914.0%

USBC-9639.0%

ROIC (TTM)

EIKN-11966.0%

USBC-11297.0%

Cash

EIKN$143M

USBC$3M

Debt

EIKN$0

USBC$15M

Net Cash/Debt

EIKN$143M

USBC$-12M

Current Ratio (TTM)

EIKN9.89x

USBC0.23x

Quick Ratio (TTM)

EIKN9.61x

USBC0.20x

Debt/Equity (TTM)

EIKN0.00x

USBC0.32x

Debt/Assets (TTM)

EIKN0.0%

USBC0.0%

Interest Coverage (TTM)

EIKNN/A

USBCN/A

Net Debt/EBITDA (TTM)

EIKN0.00x

USBC0.00x

Beta

EIKN1.90

USBC2.77

52W Performance

EIKN-50.2%

USBC-51.9%

YTD Performance

EIKN-50.2%

USBC-22.2%

% from 52W High

EIKN-57.1%

USBC-60.5%

% from 52W Low

EIKN6.5%

USBC78.7%

Asset Turnover (TTM)

EIKN0.00x

USBC0.00x

FCF Yield (TTM)

EIKN-96.6%

USBC-11.6%

Earnings Yield (TTM)

EIKN-124.9%

USBC-43.5%

Dividend Yield (TTM)

EIKNN/A

USBCN/A

Rule of 40

EIKN0.0

USBC0.0

EV/GP/RG

EIKNN/A

USBCN/A

Ticker research

View EIKN research View USBC research

Metric	EIKN Eikon Therapeutics Inc	USBC USBC Inc
Market & Valuation
Market Cap	$404M	$198M
Enterprise Value	$262M	$210M
Price	$7.47	$0.51
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.85x	4.46x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.67x	-9.14x
PEG Ratio	0.00x	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	436.8%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-505M	$-86M
FCF (TTM)	$-391M	$-23M
EPS (TTM)	-$9.33	-$0.22
ROE (TTM)	-11966.0%	-12093.0%
ROA (TTM)	-6914.0%	-9639.0%
ROIC (TTM)	-11966.0%	-11297.0%
Financial Health
Cash	$143M	$3M
Debt	$0	$15M
Net Cash/Debt	$143M	$-12M
Current Ratio (TTM)	9.89x	0.23x
Quick Ratio (TTM)	9.61x	0.20x
Debt/Equity (TTM)	0.00x	0.32x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.90	2.77
52W Performance	-50.2%	-51.9%
YTD Performance	-50.2%	-22.2%
% from 52W High	-57.1%	-60.5%
% from 52W Low	6.5%	78.7%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-96.6%	-11.6%
Earnings Yield (TTM)	-124.9%	-43.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View EIKN research	View USBC research

Valuation

P/S Ratio

EIKN

0.00x

USBC

0.00x

EV/FCF

USBC

-9.14x

EIKN

-0.67x

Growth & revenue

Forward Revenue Growth

EIKN

436.8%

USBC

0.0%

Profitability & performance

Gross Margin

EIKN

0.0%

USBC

0.0%

ROE

EIKN

-11966.0%

USBC

-12093.0%

FCF Yield %

USBC

-11.6%

EIKN

-96.6%

52-Week Performance

EIKN

-50.2%

USBC

-51.9%

Detailed metrics comparison

EIKN

Eikon Therapeutics Inc

USBC

USBC Inc

Market Cap

EIKN$404M

USBC$198M

Enterprise Value

EIKN$262M

USBC$210M

Price

EIKN$7.47

USBC$0.51

P/E Ratio

EIKNN/A

USBCN/A

P/S Ratio

EIKN0.00x

USBC0.00x

EV/Sales

EIKN0.00x

USBC0.00x

EV/EBITDA

EIKN0.00x

USBC0.00x

P/B Ratio

EIKN0.85x

USBC4.46x

P/FCF Ratio

EIKNN/A

USBCN/A

EV/FCF

EIKN-0.67x

USBC-9.14x

PEG Ratio

EIKN0.00x

USBCN/A

Forward P/E (NTM)

EIKNN/A

USBCN/A

Forward P/S (NTM)

EIKNN/A

USBCN/A

Revenue (TTM)

EIKN$0

USBC$0

Revenue Growth (YoY)

EIKNN/A

USBCN/A

Forward Rev Growth

EIKN436.8%

USBC0.0%

Gross Margin (TTM)

EIKN0.0%

USBC0.0%

Operating Margin (TTM)

EIKN0.0%

USBC0.0%

EBITDA Margin (TTM)

EIKN0.0%

USBC0.0%

Net Margin (TTM)

EIKN0.0%

USBC0.0%

FCF Margin (TTM)

EIKNN/A

USBCN/A

Net Income (TTM)

EIKN$-505M

USBC$-86M

FCF (TTM)

EIKN$-391M

USBC$-23M

EPS (TTM)

EIKN-$9.33

USBC-$0.22

ROE (TTM)

EIKN-11966.0%

USBC-12093.0%

ROA (TTM)

EIKN-6914.0%

USBC-9639.0%

ROIC (TTM)

EIKN-11966.0%

USBC-11297.0%

Cash

EIKN$143M

USBC$3M

Debt

EIKN$0

USBC$15M

Net Cash/Debt

EIKN$143M

USBC$-12M

Current Ratio (TTM)

EIKN9.89x

USBC0.23x

Quick Ratio (TTM)

EIKN9.61x

USBC0.20x

Debt/Equity (TTM)

EIKN0.00x

USBC0.32x

Debt/Assets (TTM)

EIKN0.0%

USBC0.0%

Interest Coverage (TTM)

EIKNN/A

USBCN/A

Net Debt/EBITDA (TTM)

EIKN0.00x

USBC0.00x

Beta

EIKN1.90

USBC2.77

52W Performance

EIKN-50.2%

USBC-51.9%

YTD Performance

EIKN-50.2%

USBC-22.2%

% from 52W High

EIKN-57.1%

USBC-60.5%

% from 52W Low

EIKN6.5%

USBC78.7%

Asset Turnover (TTM)

EIKN0.00x

USBC0.00x

FCF Yield (TTM)

EIKN-96.6%

USBC-11.6%

Earnings Yield (TTM)

EIKN-124.9%

USBC-43.5%

Dividend Yield (TTM)

EIKNN/A

USBCN/A

Rule of 40

EIKN0.0

USBC0.0

EV/GP/RG

EIKNN/A

USBCN/A

Ticker research

View EIKN research View USBC research

Metric	EIKN Eikon Therapeutics Inc	USBC USBC Inc
Market & Valuation
Market Cap	$404M	$198M
Enterprise Value	$262M	$210M
Price	$7.47	$0.51
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.85x	4.46x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.67x	-9.14x
PEG Ratio	0.00x	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	436.8%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-505M	$-86M
FCF (TTM)	$-391M	$-23M
EPS (TTM)	-$9.33	-$0.22
ROE (TTM)	-11966.0%	-12093.0%
ROA (TTM)	-6914.0%	-9639.0%
ROIC (TTM)	-11966.0%	-11297.0%
Financial Health
Cash	$143M	$3M
Debt	$0	$15M
Net Cash/Debt	$143M	$-12M
Current Ratio (TTM)	9.89x	0.23x
Quick Ratio (TTM)	9.61x	0.20x
Debt/Equity (TTM)	0.00x	0.32x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.90	2.77
52W Performance	-50.2%	-51.9%
YTD Performance	-50.2%	-22.2%
% from 52W High	-57.1%	-60.5%
% from 52W Low	6.5%	78.7%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-96.6%	-11.6%
Earnings Yield (TTM)	-124.9%	-43.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View EIKN research	View USBC research